Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

107.41
+0.61000.57%
Post-market: 108.150.7400+0.69%19:30 EDT
Volume:179.39K
Turnover:19.28M
Market Cap:1.75B
PE:10.00
High:107.94
Open:106.87
Low:106.87
Close:106.80
52wk High:108.66
52wk Low:69.02
Shares:16.30M
Float Shares:16.30M
Volume Ratio:0.76
T/O Rate:1.10%
Dividend:1.46
Dividend Rate:1.36%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities

THOMSON REUTERS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Berenberg Adjusts Price Target on Eli Lilly to $1,220 From $1,135, Maintains Hold Rating

MT Newswires Live
·
Aug 13

Switzerland's PolyPeptide H1 Revenue Rises on Stronger Metabolic Therapeutics Demand

Reuters
·
Aug 13

Eli Lilly : Berenberg Raises Target Price to $1220 from $1135

THOMSON REUTERS
·
Aug 13

Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly

TIPRANKS
·
Aug 13

Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Perrigo Co. PLC Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 13

Merck Animal Health EVP Richard R. DeLuca Sells 45,320 Merck Shares Worth $5.97 Million

Reuters
·
Aug 13

Royalty Pharma and Zealand Pharma Enter into Rusfertide Funding Agreement for $100 Million

THOMSON REUTERS
·
Aug 13

Zealand Pharma Sells Rusfertide Royalty Interests to Royalty Pharma for USD 100 Million

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Merck Shares Rise After Daiwa Upgrade

MT Newswires Live
·
Aug 13

Why Bristol Myers Squibb (BMY) Is Back In The Spotlight

Simply Wall St.
·
Aug 13

BMY Expands Melanoma Immunotherapy Footprint With New Phase 4 Trial in India

TIPRANKS
·
Aug 13

Merck Price Target Raised to $143.00/Share from $120.00 by Daiwa Capital

Dow Jones
·
Aug 12